Stock UniverseDerived research view · source repositories remain read-only

Prelude Therapeutics Incorporated (PRLD)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
22.09
Global Rank
3085
Market Cap
227.42M
Latest Close
3.81
RS Composite
41.78% · G#181

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-21.28%
3M
17.96%
6M
176.09%
1Y
281.00%
3Y
-31.72%
5Y
-89.04%
10Y
-85.46%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 219.63K · 30-day average: 439.67K · Max drawdown over stored range: -99.33%

Research Snapshot

Relative Strength vs SPX

RS Composite41.78%
20D RS-26.66%
60D RS-8.97%
120D RS126.75%
Global RS Rank181 · 94.61% percentile
Watch+Speculative RS Rank97 · 95.37% percentile
Group ScopeWatch+Speculative
Primary RS Rank29 · 93.67% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank376 / 701
Primary Percentile46.50
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for PRLD.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0000712.14
Revenue Growth (YoY)73.429%
Gross Profit00007
Operating Income-58.763-113.735-123.54-132.277-139.714
Free Cash Flow-46.798-85.854-86.748-110.576-103.652-56.369
Free Cash Flow Per Share-3.75-1.864-1.831-1.832-1.367-0.7324816505348485
EPS (Diluted) GAAP-4.56218-2.425506-2.436861-2.018521-1.677614
EPS Growth
EPS Non-GAAP
Gross Margin2800%2800%2800%2800%100%100%
Operating Margin2800%2800%2800%2800%-1995.914%-861.3344%
Profit Margin2800%2800%2800%2800%-1816.757%-819.5881%
Free Cash Flow Margin2800%2800%2800%2800%-1480.743%-464.3245%
Shares Outstanding (Diluted)12.478546.049847.371660.357175.805876.9562
Shares Change (YoY)647.863%269.034%2.87%27.412%25.596%1.518%

SEC Quarterly Fundamentals

No processed quarterly rows for PRLD.